Manuel Muñoz Torres | Diagnostic | Innovative Research Award

Published on by Global Diseases Research

Innovative Research Award

 Manuel Muñoz Torres
Universidad De Granada

                Manuel Muñoz Torres
Affiliation Universidad De Granada
Country Spain
Scopus ID 7006824938
Documents 299
Citations 6,813
h-index 43
Subject Area Diagnostic
Event Global Diseases Research Awards
ORCID 0000-0002-9645-3260

The Innovative Research Award recognizes researchers whose scholarly contributions demonstrate sustained scientific excellence, interdisciplinary collaboration, and measurable impact on advancing diagnostic science and healthcare research. Manuel Muñoz Torres has established a significant academic record through extensive publications, influential citations, and continued participation in internationally recognized research initiatives.[1]

Abstract

Manuel Muñoz Torres is a distinguished academic affiliated with Universidad De Granada whose research has significantly contributed to diagnostic science and related biomedical disciplines. His scholarly portfolio comprises 299 indexed publications supported by more than 6,800 citations and an h-index of 43, reflecting sustained scientific influence across international research communities. His work emphasizes evidence-based clinical investigation, multidisciplinary collaboration, and the advancement of diagnostic methodologies that improve patient care and medical decision-making. These achievements demonstrate research excellence, academic leadership, and continuous knowledge dissemination, making his profile highly relevant for recognition through the Global Diseases Research Awards.[1]

Keywords

Innovative Research Award, Diagnostic Research, Clinical Investigation, Biomedical Science, Medical Diagnostics, Translational Medicine, Scientific Publications, Research Excellence, Global Diseases Research Awards, Healthcare Innovation.

Introduction

Diagnostic research plays an essential role in improving disease detection, treatment strategies, and healthcare outcomes through evidence-based scientific investigation. Researchers who consistently contribute validated findings and collaborative innovation strengthen both clinical practice and biomedical knowledge, supporting international progress in disease management and medical research.[2]

Research Profile

Manuel Muñoz Torres has developed an internationally recognized academic profile through sustained publication activity, interdisciplinary collaboration, and contributions to diagnostic medicine. His Scopus-indexed research output, citation performance, and h-index collectively indicate consistent scholarly productivity and continuing influence across biomedical research communities.[1]

Research Contributions

His scientific contributions encompass diagnostic methodologies, clinical evaluation, translational medicine, and collaborative healthcare research. Through peer-reviewed investigations, he has supported the development of improved diagnostic understanding while promoting evidence-based medical practices that benefit both researchers and healthcare professionals worldwide.[3]

Publications

The researcher’s publication portfolio includes 299 scholarly documents indexed in Scopus across diagnostic and biomedical disciplines. These publications demonstrate continuous scientific productivity and have received substantial international recognition through citations, reflecting both academic relevance and sustained research quality.[4]

Research Impact

An h-index of 43 together with 6,813 citations illustrates meaningful scholarly influence within diagnostic research. Citation performance suggests that numerous publications have contributed to subsequent scientific investigations, reinforcing the researcher’s role in advancing biomedical knowledge and encouraging continued international collaboration.[5]

Award Suitability

Based on measurable scholarly indicators, extensive publication activity, and sustained research influence, Manuel Muñoz Torres demonstrates characteristics consistent with the objectives of the Innovative Research Award. His academic achievements align with the recognition of impactful research, scientific excellence, and contributions supporting diagnostic advancement.[4]

Conclusion

The available bibliometric evidence highlights a distinguished academic career characterized by consistent productivity, significant citation impact, and meaningful contributions to diagnostic science. These accomplishments reflect a sustained commitment to scientific excellence and justify consideration within international academic recognition programs.[1]

References

  1. Elsevier. (n.d.). Scopus author details: Manuel Muñoz Torres, Author ID 7006824938. Scopus.
    https://www.scopus.com/authid/detail.uri?authorId=7006824938
  2. Global Diseases Research Awards. (2026). Innovative Research Award.
    https://globaldiseases.org/
  3. Pols, H. A., Felsenberg, D., Hanley, D. A., Stepán, J., Muñoz-Torres, M., Wilkin, T. J., Qin-sheng, G., Galich, A. M., Vandormael, K., Yates, A. J., & Stych, B. (1999). Multinational, placebo-controlled, randomized trial of the effects of alendronate on bone density and fracture risk in postmenopausal women with low bone mass: Results of the FOSIT study. Osteoporosis International, 9(5), 461–468.
    https://doi.org/10.1007/PL00004171
  4. Garber, A. J., King, A. B., Del Prato, S., Sreenan, S., Balci, M. K., Muñoz-Torres, M., Rosenstock, J., Endahl, L. A., Ocampo Francisco, A. M., Hollander, P., & NN1250-3582 (BEGIN BB T2D) Trial Investigators. (2012). Insulin degludec, an ultra-long-acting basal insulin, versus insulin glargine in basal-bolus treatment with mealtime insulin aspart in type 2 diabetes (BEGIN Basal-Bolus Type 2): A phase 3, randomised, open-label, treat-to-target non-inferiority trial. The Lancet, 379(9825), 1498–1507.
    https://doi.org/10.1016/S0140-6736(12)60205-0
  5. García-Martín, A., Rozas-Moreno, P., Reyes-García, R., Morales-Santana, S., García-Fontana, B., García-Salcedo, J. A., & Muñoz-Torres, M. (2012). Circulating levels of sclerostin are increased in patients with type 2 diabetes mellitus. The Journal of Clinical Endocrinology & Metabolism, 97(1), 234–241.
    https://doi.org/10.1210/jc.2011-2186

Hossain Mohammad Ismail | Disease Mapping | Young Researcher Award

Published on by Global Diseases Research

Assist. Prof. Dr. Hossain Mohammad Ismail | Disease Mapping | Young Researcher Award

Assistant Professor | Khulna University Of Engineering & Technology | Bangladesh

Dr. Mohammad Ismail Hossain, Ph.D., is an Assistant Professor at the Institute of Disaster Management, Khulna University of Engineering & Technology (KUET), Bangladesh, renowned for his interdisciplinary research in protected area management, disaster management policy, eco-tourism, and biodiversity conservation. With over 20 publications and 88 citations (h-index 5, i10-index 3), his work integrates geospatial technologies, ecosystem assessment, and sustainability science to address complex environmental and socio-economic challenges. Dr. Hossain’s influential studies, such as the SWOT analysis of forest protected area-based sustainable tourism development and Ecosystem Services of the Sundarbans, contribute significantly to the understanding of sustainable resource utilization and conservation planning in vulnerable regions. His research extends to flood susceptibility mapping, land-use change detection, water quality assessment, and livelihood adaptation in disaster-prone areas, offering actionable insights for policymakers and stakeholders. Collaborating with international scholars including Dr. Shinya Numata and Dr. Bishnu Prasad Khanal from Tokyo Metropolitan University, he has advanced cross-border environmental and conservation dialogues. His recent works emphasize remote sensing and GIS applications for natural resource management and disaster resilience, underscoring his commitment to science-based environmental governance. Through his scholarly endeavors, Dr. Hossain has made enduring contributions to sustainable development, ecosystem restoration, and disaster risk reduction, reinforcing his standing as a distinguished researcher and educator dedicated to fostering environmental resilience and sustainable futures in Bangladesh and beyond.

Profiles: Google Scholar | ORCID

Featured Publications

1. Hossain, M. I., & Khanal, B. P. (2020). SWOT analysis of forest protected area based sustainable tourism development: A case study in the Lawachara National Park, Bangladesh. Journal of Tourism and Hospitality Education, 10, 71–89.
Cited by: 28

2. Hossain, M. I., Nabi, M. R., Ansari, M. N. A., Latif, A., Mahmud, M., & Islam, M. S. (2016). Ecosystem services of the world’s largest mangrove forest Sundarban in Bangladesh. International Journal of Innovation and Scientific Research, 27(1), 9.
Cited by: 16

3. Nabi, M. R., Rashid, M. S., & Hossain, M. I. (2016). Historical bankline shifting since 1760s: A GIS and remote sensing based case study of Meghna river plate of Rennell’s atlas. International Journal of Scientific and Research Publications, 6(12), 473–483.
Cited by: 14

4. Das, O. C., Alam, M. J., Hossain, M. I., Hoque, M. M., & Barua, S. (2021). Factors determining the smallholder milk producers’ participation in contractual agreements: The case of North-West Bangladesh. International Journal of Sustainable Agricultural Research, 8(3), 164–179.
Cited by: 8

5. Hossain, M. I., Ansari, M. N. A., & Saika, U. (2017). Lake base urban recreation in Dhaka metropolitan area: Hatirjheel Lake as a potential case. International Journal of Research – Granthaalayah, 5(12), 266–274.
Cited by: 6

Bruno Oliveira Souza e Silva | Diagnostic | Best Innovation Award

Published on by Global Diseases Research

Mr. Bruno Oliveira Souza e Silva | Diagnostic | Best Innovation Award 

Public servant | State Secretariat of Health of Minas Gerais | Brazil

Bruno Oliveira Souza e Silva is a dedicated Brazilian pharmacist and health professional with extensive experience in clinical analysis, laboratory coordination, and public health. He holds a Bachelor’s degree in Pharmacy with specialization in Clinical and Toxicological Analysis from the José do Rosário Vellano University, a Master’s degree in Health Education from UFVJM, and multiple postgraduate specializations in Chemistry, Higher Education Teaching, Environmental Health Surveillance, and Health Surveillance. Currently serving as a Clinical Analyst Pharmacist at the State Health Secretariat of Minas Gerais, he coordinates the Macrorregional Laboratory of Teófilo Otoni, overseeing diagnostic services for tuberculosis, leishmaniasis, and leprosy. His professional background also includes teaching roles at the Doctum University Center of Teófilo Otoni, where he contributes to Pharmacy, Dentistry, Nursing, and Biomedical programs. An alumnus of the EpiSUS Fundamental Program, he is also a Field Epidemiologist and member of the Technical Working Group on Clinical and Toxicological Analysis of the Regional Pharmacy Council of Minas Gerais. Bruno’s expertise spans pharmacy, biochemistry, microbiology, parasitology, and pharmacology, supported by a robust record of research and publication in disease surveillance, epidemiology, and laboratory science. His commitment to innovation and public health excellence has earned him several distinctions, including the Pharmaceutical Attitude Award (2024) and the Inova Minas Gerais Award (2021) for public policy innovation. Passionate about scientific education and health system strengthening, he continues to advance integrated approaches to laboratory diagnostics, disease prevention, and epidemiological surveillance in Brazil’s public health sector.

Profile: ORCID

Featured Publications

Tokai, B. O., & Costa, A. S. (2021). Estudo sobre a qualidade da água para consumo humano e as doenças diarreicas no Brasil. Revista Baiana de Saúde Pública, 43(4), e2979. Cited by: 3

 

Liancai Mu | Diagnostic | Best Researcher Award

Published on by Global Diseases Research

Prof. Liancai Mu | Diagnostic | Best Researcher Award

Senior Scientist | Hackensack Meridian Health | United States

Prof. Liancai Mu, M.D., Ph.D., is a Senior Scientist at the Upper Airway Research Laboratory, Center for Discovery & Innovation, Hackensack Meridian Health, with over three decades of academic and clinical experience in otolaryngology and neuroscience. His research focuses on the neuromuscular specializations of human upper airway structures and the mechanisms underlying speech, swallowing, and voice (SSV) disorders, particularly in Parkinson’s disease (PD). Mu’s pioneering work demonstrated that PD affects the peripheral nervous system of the pharynx and larynx, contributing significantly to SSV impairments, and led to the development of novel diagnostic and therapeutic approaches. He mapped the nerve supply of laryngeal, pharyngeal, soft palate, and tongue muscles using Sihler’s staining technique and identified neuromuscular compartments with specialized fibers, leading to a new theory that pharyngeal constrictors are controlled by two distinct neuromuscular systems (IX-SIL and X-FOL), now included in modern medical texts. Additionally, he developed an innovative muscle reinnervation method, “nerve-muscle-endplate grafting” (NMEG), which achieves superior functional recovery compared to traditional nerve repair. Mu has led multiple NIH R01, DOD, and Michael J. Fox Foundation-funded projects, collaborated internationally with institutions such as Mount Sinai Medical Center, Linguaflex, Inc., and the Arizona Study of Aging and Neurodegenerative Disorders, and served as a consultant for FDA-approved therapies. He has published 68 peer-reviewed articles across 22 indexed journals, accrued 2,772 citations and holds an h-index of 30, reflecting his substantial impact in neuroscience, otolaryngology, and PD research.

Profile:  Scopus

Featured Publications